Outcomes in Partial Liver Transplantation: Deceased Donor Split-liver Vs. Live Donor Liver Transplantation
Overview
Affiliations
Background: Organ shortage has resulted in greater emphasis on partial liver transplantation (PLT) as an alternative to whole-organ liver transplantation.
Methods: This study was conducted to assess outcomes in PLT and to compare outcomes of deceased donor split-liver transplantation (DD-SLT) and live donor liver transplantation (LDLT) in adults transplanted in the USA using data reported to the United Network for Organ Sharing in the era of Model for End-stage Liver Disease (MELD) scores.
Results: Between 2002 and 2009, 2272 PLTs were performed in the USA; these represented 5.3% of all liver transplants carried out in the country and included 557 (24.5%) DD-SLT and 1715 LDLT (75.5%) procedures. The most significant differences between the DD-SLT and LDLT groups related to mean MELD scores, which were lower in LDLT recipients (14.5 vs. 20.9; P < 0.001), mean recipient age, which was lower in the LDLT group (50.7 years vs. 52.8 years; P < 0.001), and mean donor age, which was lower in the DD-SLT group (23.0 years vs. 37.3 years; P < 0.001). Allograft survival was comparable between the two groups (P= 0.438), but patient survival after LDLT was better (P= 0.04). In Cox regression analysis, LDLT was associated with better allograft (hazards ratio [HR]= 0.7, 95% confidence interval [CI] 0.630-0.791; P < 0.0001) and patient (HR = 0.6, 95% CI 0.558-0.644; P < 0.0001) survival than DD-SLT.
Conclusions: Partial liver transplantation represents a potentially underutilized resource in the USA. Despite the differences in donor and recipient characteristics, LDLT is associated with better allograft and patient survival than DD-SLT. A different allocation system for DD-SLT allografts that takes into consideration cold ischaemia time and recipient MELD score should be considered.
Li Z, Sng Y, Chen C, Lin C, Wang S, Yong C Hepatobiliary Surg Nutr. 2024; 13(3):425-443.
PMID: 38911194 PMC: 11190508. DOI: 10.21037/hbsn-23-178.
Garzali I, Akbulut S, ALoun A, Naffa M, Aksoy F World J Gastrointest Surg. 2023; 15(7):1522-1531.
PMID: 37555109 PMC: 10405112. DOI: 10.4240/wjgs.v15.i7.1522.
The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases.
Nikokiraki C, Psaraki A, Roubelakis M Cells. 2022; 11(9).
PMID: 35563716 PMC: 9101582. DOI: 10.3390/cells11091410.
de Ville de Goyet J, Illhardt T, Chardot C, Dike P, Baumann U, Brandt K J Clin Med. 2022; 11(8).
PMID: 35456234 PMC: 9032543. DOI: 10.3390/jcm11082142.
Zimmerman A, Flahive J, Hertl M, Cosimi A, Saidi R Int J Organ Transplant Med. 2017; 7(2):69-76.
PMID: 28435638 PMC: 5396054.